Inventor
Dinesh V. Patel
Inventor
Fremont, CA, US
Overview
Patents· 55 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
C07DHeterocyclic compounds23%
C07KPeptides14%
A61KPreparations for medical, dental or toiletry purposes13%
C40BCombinatorial chemistry7%
C07CAcyclic or carbocyclic compounds6%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium5%
G01NInvestigating or analysing materials by determining their chemical or physical properties3%
C07HSugars1%
C12NMicroorganisms or enzymes1%
PatentTitleYear
10,787,490Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases202010,626,146a4b7 thioether peptide dimer antagonists202010,407,468Methods for synthesizing a4b7 peptide antagonists201910,301,371Cyclic monomer and dimer peptides having integrin antagonist activity201910,196,424Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases201910,059,744a4b7 thioether peptide dimer antagonists201810,035,824Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases201810,023,614Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases20189,809,623'α4β7 peptide monomer and dimer antagonists'20179,714,270'a4B7 integrin thioether peptide antagonists'20179,624,268'Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases'20179,518,091'A4B7 peptide monomer and dimer antagonists'20169,273,093'α4β7 peptide dimer antagonists'20168,153,630'Kinase inhibitors'20127,772,245'Inhibitors of histone deacetylase'20107,691,843'N-hydroxyamide derivatives possessing antibacterial activity'20107,612,059'Pyrrolidine bicyclic compounds and its derivatives, compositions and methods of use'20097,371,875'Cytotoxic agents and methods of use'20087,345,043'Inhibitors of histone deacetylase'20087,279,494'Antimicrobial [3.1.0] bicyclohexylphenyl-oxazolidinone derivatives and analogues'20077,199,105'Lincomycin derivatives possessing antibacterial activity'20077,164,011'Lincomycin derivatives possessing antibacterial activity'20077,148,242'N-formyl hydroxylamine compounds, compositions and methods of use'20067,105,547'Antimicrobial 1-aryl dihydropyridone compounds'20067,101,874'Antimicrobial dihydrothiazine and dihydrothiopyran oxazolidinones'20067,002,020'Oxazolidinone combinatorial libraries, compositions and methods of preparation'20066,987,104'Pyrrolidine bicyclic compounds and its derivatives, compositions and methods of use'20066,884,813'Antimicrobial dihydrothiazine and dihydrothiopyran oxazolidinones'20056,875,784'Antimibicrobial [3.1.0.] bicyclic oxazolidinone derivatives'20056,869,965'Antimicrobial quinolone derivatives and use of the same to treat bacterial infections'20056,852,752'Urea compounds, compositions and methods of use and preparation'20056,828,317'Antimicrobial thiadiazinone derivatives and their application for treatment of bacterial infections'20046,797,820'Succinate compounds, compositions and methods of use and preparation'20046,743,811'Oxazalidinone compounds and methods of preparation and use thereof'20046,689,769'Antimicrobial quinolone derivatives and use of the same to treat bacterial infections'20046,562,844'Oxazolidinone combinatorial libraries, compositions and methods of preparation'20036,541,276'Methods for solid-phase synthesis of hydroxylamine compounds and derivatives and combinatorial libraries thereof'20036,531,470'Oxazolidinone combinatorial libraries, compositions and methods of preparation'20036,448,058'Methods for solid phase synthesis of mercapto compounds and derivatives, combinatorial libraries thereof and compositions obtained thereby'20026,441,005'Oxazolidinone compounds and compositions, and methods of using the same'20026,413,724'Solid phase and combinatorial library syntheses of fused 2,4-pyrimidinediones'20026,307,101'Inhibitors of metalloproteases, pharmaceutical compositions comprising same and methods of their use'20016,281,245'Methods for solid-phase synthesis of hydroxylamine compounds and derivatives, and combinatorial libraries thereof'20016,271,232'Collagenase-1 and stromelysin-1 inhibitors, pharmaceutical compositions comprising same and methods of their use'20016,239,152'Oxazolidinone combinatorial libraries, compositions and methods of preparation'20016,025,371'Solid phase and combinatorial library syntheses of fused 2,4-pyrimidinediones'20005,990,112'Inhibitors of metalloproteases pharmaceutical compositions comprising same and methods of their use'19995,932,579'Collagenase-1 and stromelysin-1 inhibitors, pharmaceutical compositions comprising same and methods of their use'19995,929,278'Inhibitors of metalloproteases, pharmaceutical compositions comprising same and methods of their use'19995,840,698'Inhibitors of collagenase-1 and stormelysin-I metalloproteases, pharmaceutical compositions comprising same and methods of their use'19985,831,004'Inhibitors of metalloproteases, pharmaceutical compositions comprising same and methods of their use'19985,523,430'Protein farnesyl transferase inhibitors'19965,510,510'Inhibitors of farnesyl protein transferase'19965,217,958'1,2-hydroxy phosphonates and derivatives thereof'19934,820,691'Amino acid 1,2-diketo derivatives as renin inhibitors'1989Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1989–1993Based in Somerset, NJ, US· patent location history
1996–2020Based in Fremont, CA, US· patent location history
1998–2001Patents assigned to AFFYMAX TECH NV (6)· patent assignee history
2000–2003Patents assigned to VERSICOR INC (5)· patent assignee history
2001–2006Patents assigned to UPJOHN CO (13)· patent assignee history
2002–2004Based in Freemont, CA, US· patent location history
2004–2009Patents assigned to VICURON PHARM INC (6)· patent assignee history
2016–2020Patents assigned to PROTAGONIST THERAPEUTICS INC (13)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| PROTAGONIST THERAPEUTICS INC | 13 | 2016–2020 |
| UPJOHN CO | 13 | 2001–2006 |
| AFFYMAX TECH NV | 6 | 1998–2001 |
| VICURON PHARM INC | 6 | 2004–2009 |
| VERSICOR INC | 5 | 2000–2003 |
Locations
| Location | Patents | Span |
|---|---|---|
| Fremont, California, US | 51 | 1996–2020 |
| Freemont, California, US | 2 | 2002–2004 |
| Somerset, New Jersey, US | 2 | 1989–1993 |